Jun 18, 2020
Asthma Not Associated With Increased Risk of Hospitalization Among COVID-19 Patients
Jun 12, 2020
Existing and Upcoming Therapies for Most Common Allergic, Infectious Diseases Including COVID-19
Apr 30, 2020
US Allergic Rhinitis Market and Competitive Landscape 2020
Apr 29, 2020
Pipeline Insights for Seasonal Allergic Rhinitis, with Coverage of Allergy Therapeutics, Glenmark Pharmaceutical and VentiRx Pharmaceuticals
Apr 16, 2020
Seasonal Allergic Rhinitis Global Clinical Trials Review, H1, 2020
Mar 24, 2020
EmphyCorp News: As Reported in The Lancet - Clinical Features of Patients Infected with the 2019 novel Coronavirus in Wuhan, China
Mar 23, 2020
The Global allergy rhinitis drugs market is expected to grow by USD 2.4 bn during 2020-2024, progressing at a CAGR of 4% during the forecast period
Mar 10, 2020
Dr. Ran Rubinstein Introduces ClariFix® for Relief from Chronic Rhinitis
Mar 10, 2020
SinuSonic Announces Publication of Study Results on First of its Kind Medical Device for Natural Relief of Nasal Congestion
Mar 04, 2020
AAAAI Urges Patients on Montelukast to Contact Their Healthcare Provider
Feb 27, 2020
Hikma and Glenmark Pharmaceuticals Enter into Exclusive Licensing Agreement for Commercialising Ryaltris(TM) Seasonal Allergic Rhinitis Nasal Spray in the US
Feb 13, 2020
Work-related Rhinitis Has Adverse Impact on Quality of Life and Work Productivity
Feb 04, 2020
Just in Time for Allergy Season, Corrales Pharmacy Now Offers AllerPops
Sep 10, 2019
Tivic Health's ClearUP Sinus Pain Relief Named Finalist At Health 2.0 Annual Launch! Competition
Jul 24, 2019
Allergic Diseases: Pipeline Offers Novel Approaches to Treat Increasingly Prevalent Conditions, with Strong Presence of Cytokine Mediators Among First-in-Class Products
Jun 04, 2019
mAPPing the New World of Allergy at EAACI Annual Congress 2019
May 02, 2019
Glenmark Therapeutics Expands Specialty Portfolio with OTIPRIO® Co-Promotion Agreement in the U.S. with Otonomy for Acute Otitis Externa Indication
Feb 25, 2019
Glenmark Pharmaceuticals Announces Results from New Analysis of Pooled Data on Ryaltris(TM), an Investigational Product for the Treatment of Seasonal Allergic Rhinitis, at the AAAAI 2019 Annual Meeting
Feb 19, 2019
Glenmark Pharmaceuticals to Present New Analysis of Pooled Data on Ryaltris(TM), an Investigational Product for the Treatment of Seasonal Allergic Rhinitis, at the AAAAI 2019 Annual Meeting
Jan 03, 2019
Tivic Health Receives FDA 510(k) Clearance To Market ClearUP(TM) To Treat Sinus Pain Associated With Allergic Rhinitis/Hay Fever